Filing Details
- Accession Number:
- 0001104659-25-012362
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-12 19:57:25
- Reporting Period:
- 2025-02-10
- Filing Date:
- 2025-02-12
- Accepted Time:
- 2025-02-12 19:57:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773427 | Springworks Therapeutics Inc. | SWTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578771 | Julie Hambleton | C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-02-10 | 13,774 | $32.27 | 17,869 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-02-10 | 13,774 | $53.01 | 4,095 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-10 | 13,774 | $0.00 | 13,774 | $32.27 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2033-05-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 1, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.02 to $40.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The shares underlying this option are fully vested.